B cell receptor, infographic and ClonoSEQ approval for CLL

[bkoffman]

Hi,

Dr. Burger at iwCLL 2019, discusses the importance of the B cell receptor and blocking it in CLL.

See: cllsociety.org/2020/01/iwcl...

The CLL Society and I were featured in USA Today in this informative sponsored infographic on CLL. Pretty cool.

cllsociety.org/about-us/cll...

Last week, ClonoSEQ, a test that uses next generation sequencing (NGS) to measure deeper levels of minimal residual disease, was approved by Medicare to be paid for in CLL. Read why this is good news in my opinion.

cllsociety.org/2020/01/new-...

Stay strong.

We are all in this together.

Brian

Brian Koffman MDCM (retired) MS Ed

Co-Founder, Executive VP and Chief Medical Officer

CLL Society, Inc.

cllsociety.org